drugset / Trial / NCT05441930

A Study of Levofloxacin Ocular Implant in Patients Undergoing Routine Bilateral Cataract Surgery

NCT05441930

Phase 1 Withdrawn PolyActiva Pty Ltd
RandomizedParallel-groupOpen-labelTreatment

Summary

Open label controlled interventional study in eyes in up to 12 subjects (24 eyes) scheduled for uncomplicated bilateral cataract surgery on separate days.

Timeline

Start
2023-06-23
Primary completion
2023-12-15
Completion
2024-03-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Levofloxacin Small molecule Other

Indications